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ABSTRACT
Rab Proteins and Alzheimers: A Current Review of Their Involvement in
Amyloid Beta Generation with Focus on Rab10 Expression
in N2A-695 Cells
Ivan Arano Rodriguez
Department of Biology, BYU
Master of Science
This thesis work describes the role of Rab proteins in amyloid processing and clearance
in different cell pathways. It also describes an experimental approach used to analyze the
expression effects of Rab10 in amyloid beta production. Since the main theory behind
neurodegeneration in Alzheimer’s disease claims that high levels of amyloid beta 42 (Aβ42)
molecules trigger widespread neuronal death, control of Aβ42 has been a main target in
Alzheimer’s disease research. In addition, several studies show increased levels of particular Rab
proteins in Alzheimer’s pathogenesis. However, no review consolidates current findings in
neurodegeneration of Alzheimer’s with Rab protein dysfunction. The first chapter of this thesis
aims to address this need by providing a current review of Rab proteins associated with APP and
neurodegeneration. The second chapter constitutes an experimental approach used to
characterize the effects of Rab10 and Sar1A GTPases in APP and amyloid processing. We found
that Rab10 expression does not affect APP production but significantly changes Aβ generation,
particularly the toxic Aβ42 and Aβ42:40 ratio. On the other hand, we found no significant effect
of Sar1A expression on either APP or amyloid beta generation. These findings partially confirm
the work done by Kauwe et al (2015) and provide preliminary evidence for two potential targets
for protective effects in neurodegeneration.

Keywords: Rab proteins, GTPases, Alzheimer’s disease, gene, genetic variants, 3’ UTR, amyloid
beta, neurodegeneration, endocytosis, anterograde transport, autophagy, amyloid precursor
protein, transient transfection, overexpression, knockdown
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CHAPTER 1: Rab Gtpases in Alzheimer’s Disease: A Review on Main Players
That Influence Amyloid Production
Alzheimer’s disease is the most common form of dementia and it is the sixth leading
cause of death in the United States. In 2014, an estimated 5.2 million Americans developed
Alzheimer’s disease and the cost for caregiving to be $214 billion (Plassman, Langa et al. 2007).
Amyloid production resulting by processing of APP is the main hypothesis associated with
triggering the development of this disease. Rab GTPases are small proteins belonging to the Ras
superfamily. Due to their major role in intracellular and membrane trafficking, some Rab
GTPases have been identified as important players in regulating APP transport, processing and
clearance. Consistent with these roles, AD brains present expression changes of Rab proteins
involved in these processes. This review aims to provide a framework to understand those Rab
GTPases associated with APP and neurodegeneration and to propose targets for future
Alzheimer’s disease research relating to this group of proteins.
APP Function and Amyloid Production
The most accepted theory for neurodegeneration in Alzheimer’s disease is the widespread
neuronal death triggered by high levels of a molecule called amyloid beta 42 (Aβ-42), which is
produced by the cleaving of trans membrane amyloid precursor protein (APP) (Masters,
Multhaup et al. 1985, Glenner and Wong 2012). This is commonly known as the amyloid
cascade hypothesis (Hardy and Higgins 1992). The human APP gene is located in chromosome
21 and produces a type I protein with a large extracellular N-terminal, transmembrane and short
C-terminal cytoplasmic domain (Reinhard, Hebert et al. 2005). APP is highly expressed in the
brain and produces eight isoforms that range from 365 – 770 amino acids. The 695 isoform is the
most expressed in the central neural system while the other isoforms can be ubiquitously
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expressed in all tissues (Placido, Pereira et al. 2014). Several studies have proposed a variety of
functions for APP in the brain; the most supported is the trophic effect on formation and
regulation of synapses as well as neuritic outgrowth (Turner, O'Connor et al. 2003, Lee, Moussa
et al. 2010). Additional evidence suggests APP is involved in synaptic plasticity (Hung, Koo et
al. 1992, Oh, Savonenko et al. 2009), cell adhesion (Yamazaki, Koo et al. 1997, Sosa, Bergman
et al. 2013), migration (Young-Pearse, Bai et al. 2007), axonal transport (Sisodia 2002), cell
surface receptor (Selkoe 2001, Hashimoto and Matsuoka 2014) among others.
After expression, newly formed APP undergoes the constitutive secretory pathway where
is subsequently internalized to the cell via clathrin mediated endocytosis (here referred as
endocytosis) for processing. As part of the secretory pathway, APP undergoes several posttranslation modifications in the ER and in the trans-Golgi network (TGN) including N- and Oglycosylation, cytoplasmic phosphorylation and sulfation (Selkoe 2001, Bhattacharyya, Barren et
al. 2013) before being trafficked to the plasma membrane. In neurons, APP is mainly transported
to the cell membrane of axons and dendrites using the axonal transport system with kinesin-1 as
the main motor protein (Kins, Lauther et al. 2006). Although APP is mainly processed via
endocytosis, evidence suggests that nascent APP molecules can be processed by intracellular
transport from the TGN to the endosome, resulting on increased Aβ-42 production in these
organelles (Capell, Meyn et al. 2002, Tam, Seah et al. 2014)
Different studies estimate that about 10% of APP is present on the plasma membrane at
all times while the rest is carried into the cell via endocytosis for processing (Thinakaran and
Koo 2008). APP has three main proteolytic sites (alpha, beta & gamma) and different enzymes
termed secretases are used to cleave APP on each site. APP is processed in two pathways: the
non-amyloidogenic pathway and the toxic or amyloidogenic pathway. The non-amyloidogenic
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pathway is carried in the plasma membrane where APP is first cleaved in the N- terminus by
alpha-secretase to produce sAPPα. The C- terminal is then cleaved by gamma-secretase to
produce a short p3 and APP intracellular domain fragments (Reinhard, Hebert et al. 2005,
Dawkins and Small 2014). In the amyloidogenic pathway, APP molecules not cleaved by alphasecretase are internalized and processed by beta- secretase (BACE1) and the gamma- secretase
complex (PSEN1 or PSEN2, nicastrin, APH1 & PEN-2) to produce sAPPβ and AB fragments
ranging from 38-42 amino acids (Kamenetz, Tomita et al. 2003, Dawkins and Small 2014). This
process is carried by the secretory and recycling pathways, where some APP fragments can be
recycled back to the cell membrane along with sAPP-B and AB fragments. Most of the secreted
amyloid beta produced contains 40 amino acids (Aβ40), however, the smaller portion of amyloid
beta that contains 42 amino acids (Aβ42) tends to form extracellular aggregates (Haass, Kaether
et al. 2012). The processing, aggregation and subsequent neuronal death triggered by Aβ42
fibrils are the center of the amyloid cascade hypothesis. Extensive reviews of amyloid processing
and function can be accessed in references (Kamenetz, Tomita et al. 2003, Dawkins and Small
2014). Since APP is internalized to produce Aβ42, the main steps in this process, which include
endocytosis and proteolytic processing via recycling and autophagy pathways will be analyzed
next.
Endocytosis Pathway in Alzheimer’s Pathogenesis
Endocytosis is a process by which many molecules enter the cytoplasm via cell
membrane receptors. Specific cell membrane receptors contain signal domains that trigger the
recruitment of clathrin molecules and the endocytic response, which engulfs the portion of the
cell membrane containing the cell receptor along with other molecules around it. The
intracellular and C- terminal domains of APP contain a YEMPTY motif that has been
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demonstrated to be involved in the signal for endocytosis (Nordstedt, Caporaso et al. 1993, Ring,
Weyer et al. 2007). Consistent with this observation, mutations on the YEMPTY domain inhibit
APP internalization and Aβ42 generation, suggesting that endocytosis is critical for AB
production (Perez, Soriano et al. 1999). The YEMPTY domain also serves as the binding site for
other cytosolic adaptors including Mint1, Mint2, Mint3, Fe65, Dab1 and JNK protein members
(Thinakaran and Koo 2008). Interestingly, Mint and Fe65 proteins also play an important role in
APP endocytosis and Aβ42 regulation (Haass, Kaether et al. 2012, Perez, Soriano et al. 1999,
Ring, Weyer et al. 2007). A more detailed review of the YEMPTY region of APP and predicted
interactions can be accessed in these references (Kerr and Small 2005, Miller, McLoughlin et al.
2006, Schettini, Govoni et al. 2010).
In neurons, several regulatory proteins are involved in starting the endocytosis signal of
APP; the most common are Rab5, Dynamin1 and, most recently, Mint1 and Mint2 proteins
(Thomas, Lelos et al. 2011, Sullivan, Dillon et al. 2014). Newly formed APP vesicles are
transported and fused to the first sorting station: the early endosome. Concurrently, BACE-1 is
also trafficked to the early endosome from the plasma membrane where AB biogenesis occurs.
Early endosomes are a major site for APP processing and Aβ42 production and gradually mature
into late endosomes and subsequently into lysosomes (Cataldo, Peterhoff et al. 2000, Chia, Toh
et al. 2013). Once on the early endosome, APP and AB containing vesicles can undergo different
pathways: 1) early endosome to plasma membrane 2) early endosome to recycling endosome 3)
early endosome to TGN or 4) early endosome to late endosome and lysosomes. Many studies
show evidence of high activity of BACE-1 and gamma-secretases on these sorting pathways
following endocytosis (Cataldo, Peterhoff et al. 2000, Chia, Toh et al. 2013, Lu and Hong 2014).
In addition, newly formed APP molecules that are processed in intracellular fashion are also
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incorporated into the TGN or into the lysosomes where are processed into AB peptides (Tam,
Seah et al. 2014). Consequently, AB peptides can be measured in higher quantities along these
pathways, particularly on the TGN and endosomes. Thus, keeping track of AB peptides have
become a good indicator for APP processing cycle in the cell. Finally, the autophagy mechanism
in the cell completes the APP processing cycle by recycling and secreting AB peptides to the
extracellular space.
Macroautophagy (here referred as autophagy) serves as the main clearance mechanism
for APP processing and AB clearance. During autophagy, double membrane vesicles that contain
waste components and hydrolases are fused into large vesicles called autophagosomes.
Autophagosomes then fuse with late endosomes, which eventually turn into lysosomes to
degrade the original autophagosome components (Nixon 2007). The resulting products can be
either recycled back as an amino acid source or secreted via exocytosis. A complete review of
autophagy and its involvement in amyloidogenesis can be found in reference (Nixon 2007). In
neurons, autophagosomes and endosomes are formed near the synapses and require retrograde
transport to the lysosomes for efficient degradation (Nixon 2007). Briefly, as APP is processed in
the endocytosis and intracellular pathways, the resulting AB peptides are mostly degraded by
lysosomes. Upon reaching to the lysosomes, large pools of gamma-secretase components and
other hydrolases complete the degradation process of APP and AB peptides, in which some
Aβ42 is secreted via exocytosis (LeBlanc and Goodyer 1999, Rajendran, Honsho et al. 2006)
Additional experiments show that Aβ42 was reduced when autophagy was suppressed,
highlighting the role of autophagy on Aβ clearance (Lee, Yu et al. 2010).
Although endocytosis and autophagy are vital processes in APP turnover cycle, their
disruption can also facilitate intracellular Aβ aggregation and apoptosis in the brain. In a model
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by Yu et al. (2005), autophagy vacuoles containing full length APP and Aβ peptides accumulated
in significant numbers in axons and neurites in Alzheimer’s disease brains. These vacuoles were
enriched in gamma-secretase activity inducing intracellular Aβ accumulation (Yu, Cuervo et al.
2005). A different study by Lee et al (2010)) showed that PSEN1 mutations in Familiar AD
cases affected the autophagy turnover of proteins (Lee, Yu et al. 2010). In familiar AD,
mutations along APP & gamma-secretase complex (PSEN1 & PSEN2) increase the ratio of
Aβ40 to Aβ42 (Lee, Yu et al. 2010). In late-onset AD, multiple genes that regulate endocytosis
or Aβ clearance have been, unsurprisingly associated with AD (Wu and Yao 2009, Ridge, Ebbert
et al. 2013). Examples of these genes involve BIN1, PICALM, CR1, CDAP2, and some Rab
GTPases. This paper will focus solely on the role of Rab GTPases involved in APP trafficking,
processing and clearance.
Rab GTPases in Alzheimer’s Disease
Rab GTPases are small proteins member of the Ras superfamily of monomeric proteins.
They are involved in every step of the intracellular vesicle transport in the cell. Approximately
60 human Rab GTPases have been identified, being this family the largest and more
heterogeneous of the Ras superfamily (Stenmark and Olkkonen 2001, Zerial and McBride 2001).
Rab proteins are present in all eukaryotic cells, ranging from the most evolutionary conserved
which are ubiquitously expressed for normal vesicle transport to the most specialized types that
are only found on certain mammalian cell types (Seabra, Mules et al. 2002, Kaddai, Le
Marchand-Brustel et al. 2008). Rab proteins switch between an inactive (GDP-bound) cytosol
state and active (GTP-bound) membrane bound state. To switch from the GDP to GTP state,
Rabs require activator proteins called GEFs (Guanine nucleotide exchange factors). Once in their
active state, Rab-GTP recruits effector proteins that enable them to control different steps in
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vesicle trafficking including cargo selection, tethering, movement and docking (Stenmark and
Olkkonen 2001, Seabra, Mules et al. 2002, Grosshans, Ortiz et al. 2006, Kaddai, Le MarchandBrustel et al. 2008). Once vesicle transport is complete, Rab-GTP is hydrolyzed by GAPs
(GTPase activating proteins) and return to its inactive GDP-bound state. At this point, Rab-GDP
is recycled back to the membrane of origin by binding to RabGDIs (GDP disassociation
inhibitors), which determine the proper localization and activity of Rab proteins (Alory and
Balch 2001, Markgraf, Peplowska et al. 2007).
The high number of components of the Rab family reflects the complexity of the
intracellular transport system, thus Rab proteins can be assigned to a single or multiple sites. For
instance, Rab5 plays a substantial role in endocytosis by transporting cargoes to multiple
organelles (Markgraf, Peplowska et al. 2007, Ishikura, Koshkina et al. 2008), whereas Rab23 is a
negative regulator in the Sonic hedgehog-signaling pathway (Eggenschwiler, Bulgakov et al.
2006). Because of their key role in vesicle transport, endocytosis and autophagy, Rab proteins
have also been studied as part of the amyloid hypothesis of AB deposition. Disruptions of these
pathways have been extensively documented in Alzheimer’s disease (Perez, Squazzo et al. 1996,
Nixon 2007, Wu and Yao 2009, Ridge, Ebbert et al. 2013, Tam, Seah et al. 2014). Specifically,
this review will cover the main Rab proteins associated with APP and AB production: Rab3,
Rab5, Rab6, Rab7, Rab11, Rab4 & Rab8.
Rab3
Rab3 is a small GTPase that is localized in synaptic vesicles in neural cells and thought to
be highly associated with regulating vesicle fusion in exocytosis. Rab3 has four isoforms
(Rab3A, Rab3B, Rab3C & Rab3D) that contain a 77-85% amino acid homology (Baldini, Hohl
et al. 1992). Although deletion of Rab3 causes a lethal phenotype in mice, experiments suggest
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that the role of the four isoforms might be redundant in synaptic vesicle transport (Li, Jahn et al.
1996). Rab3A is the most common of the four and localizes on the surface of synaptic vesicles of
various type of neurons in the rat brain including motor, sensory, adrenelergic and cholinergic
neurons61. More specifically Rab3A has a key role in vesicle docking in the Ca2+- dependent
exocytosis of neurotransmitters in synapses (Komuro, Sasaki et al. 1996, Coleman, Bill et al.
2007). In neurons, Rab3 protein associates with motor protein Kinesin-1 in anterograde transport
of synaptic vesicles to the neuritic axons (Schluter, Schmitz et al. 2004, Coleman, Bill et al.
2007, Kimura, Okabayashi et al. 2012). Another role of Rab3A is the association with actively
recycling vesicles carried to synapse terminals. Star et al (2007) demonstrated that vesicles that
are actively recycling contain higher Rab3A than vesicles that are stationary (Star, Newton et al.
2005). Taken together, these studies suggest that Rab3 is involved in anterograde transport and
exocytosis of synaptic vesicles in neurons.
Rab3A is required for anterograde transport of APP and is associated with regulating
APP and AB peptide levels via the secretory pathway. A study by Szodorai et al (2009) showed
that the complex required for anterograde transport of APP vesicles contained Rab3A and
Kinesin-1C. Szodorai argues that Rab3A is more important for initial recruitment of APP and
kinesin-1C rather than for the actual vesicle fusion to the axons (Szodorai, Kuan et al. 2009). A
separate study showed that a disruption of the anterograde transport increases levels of Rab3 and
it is correlated with age-dependent impartment of cognitive function (Kimura, Okabayashi et al.
2012). Rab3A was found to be significantly downregulated, among other presynaptic proteins in
the frontal and parietal cortex of AD brains (Reddy, Mani et al. 2005). Consistent with these
findings, a recent study by recent study by Tan et al (2014) showed that a Rab3A effector
Rabphilin3A (RBP3A) is also reduced in AD post-mortem brains; this reduction was correlated
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with dementia progression, cholinergic deaferrentiation and high Aβ42 aggregation (Tan, Lee et
al. 2014). In a different study, a Western Blot screening of lysosomal network proteins identified
Rab3 and Rab7 as significantly increased in CSF of AD patients and was validated using a
second cohort. This study suggested that both Rab3 and Rab7 are upregulated in the endosomal
and autophagy pathways early in disease progression (Armstrong, Mattsson et al. 2014). These
studies support the observation that Rab3 expression might be reduced in the brain and
upregulated in the CSF of Azheimer’s disease patients. Finally, a high-throughput RNAi
screening of all human Rab GTPAses confirmed the role of Rab3 in the trafficking and
maintenance of APP levels in neurons. In this same study, knockdown of all isoforms of Rab3,
except for Rab3C, decreased both Aβ42 and sAPP-β levels (Udayar, Buggia-Prevot et al. 2013).
Rab5
Rab5 is by far the most characterized member of the Rab GTPase proteins and the most
associated with AD progression. Rab5 has three known isoforms (Rab5A, Rab5B & Rab5C),
similar to Rab3; all isoforms have a similar function. Although Rab5 is widely expressed in the
cell, it is mainly localized in the early endosome, cell membrane, clathrin-coated vesicles and in
recycling endosomes (Gorvel, Chavrier et al. 1991, Bucci, Parton et al. 1992, Li and Stahl 1993,
Somsel Rodman and Wandinger-Ness 2000). The most established functions for Rab5 are the
fusion of endocytic vesicles to the early endosomes and the vesicle docking events in recycling
and endocytosis. Reviews can be accessed in references (Gorvel, Chavrier et al. 1991, Somsel
Rodman and Wandinger-Ness 2000, Woodman 2000). Additional functions for Rab5 include
promoting cell migration and integrin signaling pathways (Mendoza, Diaz et al. 2014).
Overexpression of Rab5 causes an increase of endocytosis as well as a formation of large early
endosomes whereas the opposite effects applied upon down regulation of Rab5 (Stenmark,
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Parton et al. 1994, Horiuchi, Lippe et al. 1997). Due to the critical role of Rab5 in endocytosis
and recycling pathways, there is much evidence that links Rab5 and its effectors with neuronal
degeneration and Alzheimer’s disease.
Characterization of Rab5 and its effectors in endocytosis and recycling have provided
important insights towards APP processing and AD pathogenesis. Disruptions of the afore
mentioned pathways are one of the earliest changes observed in AD and could be one of the
main mechanisms involved in the progression of this disease. Increased endocytosis markers and
endosome enlargement are one of the first responses in AD, independently of Aβ42
accumulation (Cataldo, Rebeck et al. 2001, Grbovic, Mathews et al. 2003, Nixon 2005,
Ginsberg, Mufson et al. 2011). Rab5 overexpression replicates many of these observations in
early endosomes and dramatically increases secreted Aβ40 & Aβ42 (Cataldo, Peterhoff et al.
2000, Grbovic, Mathews et al. 2003, Nixon 2005, Ginsberg, Mufson et al. 2011). A possible
mechanism is that APP functions as an endocytosis receptor for Rab5, which could trigger
overexpression of Rab5 and its correspondent downstream effects in endosomal dysfunction. A
study by Laifenfeld et al (2007) showed that Rab5 binds to APP-B1 and initiates a signaling
pathway that leads to apoptosis in a FAD model (Laifenfeld, Patzek et al. 2007). In addition,
microarray analyses show that Rab5 and Rab7 are selectively up regulated in cholinergic and
hippocampal neurons of MCI and AD individuals (Ginsberg, Mufson et al. 2010, Ginsberg,
Mufson et al. 2011). Along with these observations, the majority of Aβ production occurs in in
Rab5-endocytic vesicles in the early endosome and lysosomes. Overexpression of Rab5 and
Rab7 showed to increase Aβ42 trafficking and processing in lysosomes. This effect is further
increased in APOEe4 when compared to APOEe3 carriers (Li, Kanekiyo et al. 2012).
Interestingly, Rab5B isoform is associated with neuroprotection by providing neuronal resistance
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to exocytosis injury and synaptic plasticity (Baskys, Bayazitov et al. 2007). Similarly, silencing
of only Rab5C isoform increased significantly APP, sAPPβ and Aβ42 cellular levels (Li and
Stahl 1993). Together, these reports highlight the role of Rab5 in neurodegeneration and as a
therapeutic candidate for AD progression.
Rab6
Rab6 is another well-characterized GTPase, which is involved in anterograde and
retrograde transport of APP and Aβ peptides. Rab6 has four different isoforms: Rab6A, Rab6A’,
Rab6B and Rab6C. Rab6A’ is a splice variant generated by alternative splicing on the Rab6A
gene and only differs from Rab6A by three amino acids (Opdam, Echard et al. 2000). Rab6 GTP
is commonly found in the TGN and regulates retrograde and anterograde intra-Golgi pathways
(Martinez, Schmidt et al. 1994, Darchen and Goud 2000). In contrast to the previous Rab
GTPases, Rab6 isoforms have differential tissue expressions and functions. RabA is a dynamic
GTPase that regulates retrograde transport from the TGN to the ER in a COP-I independent
mechanism and from endosomes (early endosomes and recycling endosomes) to the TGN or vice
versa (Martinez, Schmidt et al. 1994, Young, Stauber et al. 2005). On the other hand, Rab6A’
regulates anterograde transport from the TGN to the plasma membrane(Siniossoglou and Pelham
2001, Mallard, Tang et al. 2002). Rab6B is also involved in retrograde transport in the TGN and
ER but it is expressed specifically in brain cells such as neurons, microglia and Purkinje cells
(Opdam, Echard et al. 2000, Wanschers, van de Vorstenbosch et al. 2007). Finally, Rab6C is the
least characterized of the four isoforms and it has been associated with the cell cycle progression
and drug resistance to particular cancer types (Shan, Mason et al. 2000, Young, Menetrey et al.
2010).
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In neurons, Rab6B GTP requires Mint effector proteins to bind to APP. As described
earlier, Mint proteins bind to the YENPTY motif of APP, facilitating anterograde transport.
Studies show that Rab6 can bind to Mint1, Mint2 and Mint3 to form a complex with APP
(Teber, Nagano et al. 2005, Thyrock, Ossendorf et al. 2013). Evidence suggests that Rab6 is
involved in retrograde trafficking of APP from the endosomes to the TGN and from the TGN to
the ER. However, there is not a consensus of the actual role of Rab6 in APP processing and AD.
A study by Elfrink et al (2011) showed that Rab6 is increased in non-tangle bearing neurons.
This increase might occur as a protective response to reduce ER stress neurotoxicity (Elfrink,
Zwart et al. 2012). Failure to recover from ER stress also contributes to intracellular Aβ42
accumulation and neurodegeneration in early AD pathology (Soejima, Ohyagi et al. 2013). Rab6
can also promote sAPPa production and decrease intracellular Aβ42 accumulation. A recent
study suggests that Rab6 selectively facilitates anterograde transport of APP to the plasma
membrane to be processed by alpha-secretase (McConlogue, Castellano et al. 1996). Moreover, a
recent RNAi screen showed that silencing of Rab6 decreased Aβ42 production; the authors
concluded that this effect could be a result of an alteration of the Gamma-secretase cleavage or
the secretion of Aβ (Udayar, Buggia-Prevot et al. 2013). This conclusion is in line with previous
results in fibroblasts where Rab6 is dependent on PSEN1 and protein kinase C for membrane
association (Scheper, Zwart et al. 2004). These observations suggest of a protective role of Rab6
for neurodegeneration, however, further experiments are needed to assess this specific
connection.
Rab7
Rab7 is a GPTase required in the late stages of the recycling and autophagy pathways.
Rab7 is ubiquitously expressed and it comes in one isoform. However, a new Rab GTPase that
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contains 65% identity with Rab7 has been named Rab7b. This GTPase is not coded by the same
gene and seems to have different functions than Rab7 (Progida, Cogli et al. 2010). Rab7 has a
critical role in regulating the recycling pathway, specifically in late steps in endocytosis and the
maturation of endosomes and autophagosomes (Feng, Press et al. 1995, Gutierrez, Munafo et al.
2004, Jager, Bucci et al. 2004, Rink, Ghigo et al. 2005, Hyttinen, Niittykoski et al. 2013). In late
endocytic trafficking, Rab7 acts downstream of Rab5 in transporting cargoes from early to late
endosomes (Feng, Press et al. 1995). In the process of maturation of early endosomes to late
endosomes, a crucial step is the replacement of Rab5 compartments with Rab7 via GEF effectors
and other vesicle fusion events (Rink, Ghigo et al. 2005, Hyttinen, Niittykoski et al. 2013). After
late-endosome maturation, cytoplasmic vesicles or other late-endosomes containing Rab7 are
fused together and aid to the formation of lysosomes according to the “kiss and run model”
(Storrie and Desjardins 1996, Bucci, Thomsen et al. 2000). Lastly, Rab7 is also required for the
final maturation of autophagic vacuoles and their final step in fusing with lysosomes. Rab7
deficient cells experience mayor failures on lysosome function and autophagy (Gutierrez,
Munafo et al. 2004, Jager, Bucci et al. 2004). The role of Rab7 in recycling and autophagy
makes it an attractive target in connection to the AB aggregation hypothesis in Alzheimer’s
disease.
As explained earlier, changes in the endocytosis and recycling pathways are one of the
earliest clinical changes in Alzheimer’s. In these pathways, Rab5 and Rab7 are critical in
maintaining normal cellular functioning. Alzheimer’s disease brains exhibit increased
endocytosis and vesicle fusion to produce enlarged early endosomes, which will later turn into
enlarged late endosomes and lysosomes with impaired functions. Rab5 and Rab7 are common
markers used to visualize each step on these events (Cataldo, Mathews et al. 2008, Ginsberg,
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Alldred et al. 2010) and consequently, these seem to be upregulated in mild cognitive impaired
and Alzheimer’s disease patients (Yuyama and Yanagisawa 2009, Ginsberg, Mufson et al. 2010,
Ginsberg, Mufson et al. 2011). A recent study by Armstrong et al (2014) identified Rab7 as one
of six lysosomal proteins that could be used for potential Alzheimer’s disease biomarkers in
cerebrospinal fluid (Armstrong, Mattsson et al. 2014). Indeed, in Alzheimer’s disease brains, an
excessive number of autophagic vacuoles accumulate in neurites and synaptic terminals as a
result of disruption of autophagy and lysosome pathways (Nixon, Wegiel et al. 2005). Moreover,
autophagic vacuoles in axons fuse with Rab7 vesicles to form lysosomes via retrograde transport
to the cell for degradation. Lee et al (2011) demonstrated that disruption of this pathway in
mouse cortical neurons produced AD-like axonal dystrophy (Lee, Sato et al. 2011). An
interesting study concluded that amyloid fibrils are formed as a result of Rab7 suppression,
whereas Rab5 knockdown did not seem to affect amyloid aggregation. The authors concluded
that dysfunction of the late endocytosis pathway; controlled by Rab7, contribute to amyloid
aggregation in neuronal cells (Yuyama and Yanagisawa 2009). A follow-up study showed that
inhibiting Aβ42 endocytosis reversed the increased levels of Rab7 and Rab5 and prevented
neurodegeneration in mice neurons treated with Aβ42 (Song, Baker et al. 2011). Overall, the role
Rab7 in the late endocytosis pathway provides important insights into Aβ42 production and
could be a useful therapeutic target in Alzheimer’s disease.
Rab11
Rab11 is a very dynamic player in different cell functions ranging from cell adhesion to
endocytosis. Rab11 comes in three isoforms: Rab11A is ubiquitously expressed in mammalian
cells, Rab11B which is mainly expressed in brain cells and Rab11C, which is known as Rab25
(Goldenring, Shen et al. 1993, Lai, Stubbs et al. 1994, Hales, Griner et al. 2001). Rab11 has a
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fundamental role in the recycling endosome by controlling trafficking of proteins to and from the
recycling endosome to other organelles in the recycling pathway (Urbe, Huber et al. 1993,
Ullrich, Reinsch et al. 1996). Rab11 is also localized in compartments of the TGN, post-TGN
vesicles and in vesicles for exocytosis, suggesting Rab11 as an important link between
endocytosis and exocytosis (Urbe, Huber et al. 1993, Chen, Feng et al. 1998, Wilcke, Johannes et
al. 2000). Recent studies also show that Rab11 promotes ciliogenesis, cell adhesion and
cytokinesis functions by binding to several cell receptors and adhesion proteins (Knodler, Feng
et al. 2010, Kelly, Horgan et al. 2012). Finally, Rab11 and its effector proteins associate with
motor proteins such as myosin VA and dynein-1 in regulating transport along microtubule tracks
(Welz, Wellbourne-Wood et al. 2014). Due to its importance in cell adhesion, Rab11C (Rab25)
has been more characterized in Cancer biology; however, several new studies provide important
insights towards the relation of Rab11 with neurodegeneration in AD.
Rab11 regulates Aβ42 production by associating with the beta- and gamma- secretases
but not directly to APP. Ubayar et al (2013) performed RNAi screenning of all human Rab
GTPases and identified Rab11 as a key regulator of sAPP-B and Aβ42 production by controlling
trafficking of BACE-1 in endocytic compartments (Udayar, Buggia-Prevot et al. 2013). This
observation is supported by other studies that confirm the trafficking of BACE-1 from axons and
dendrites to the early endosomes in a Rab11-dependent manner (Chia, Toh et al. 2013, BuggiaPrevot, Fernandez et al. 2014). After internalized in endocytosis, APP and BACE-1 converge in
the early endosome where Aβ42 production is initiated. Rab11 impairment decreases BACE-1
endocytosis and has the same effect in sAPP-β and secreted Aβ42 (Udayar, Buggia-Prevot et al.
2013, Buggia-Prevot, Fernandez et al. 2014). However, other studies used HEK293 cells
expressing the Swedish mutation to show that sAPP-β and Aβ42 are not affected by Rab11
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expression (Lopez-Perez, Dumanchin et al. 2000, Bulloj, Leal et al. 2010). Whether these
contrasting observations are obtained because of the different cell type used remains to be
elucidated. In the gamma-secretase complex, hydrophilic loops in PSEN1 and PSEN2 proteins
interact with Rab11; however, this association did not seem to influence APP transport or
processing in a negative way (Dumanchin, Czech et al. 1999, Lopez-Perez, Dumanchin et al.
2000). Altogether, Rab11 is a newly identified target that is associated with increased LOAD risk
likely by the regulation of BACE-1 and Aβ42. Further studies of Rab11 regulation could provide
important insights into therapeutic mechanisms in neurodegeneration.
The Rab GTPases reviewed above are the most associated with amyloid processing and
neurodegeneration in AD. However, there are other Rab proteins which association with
neurodegeneration is less documented. These Rab proteins are often associated with some of the
Rabs reviewed here either by localizing to the same organelle or by regulating the same
pathways. A quick overview of such less documented Rab proteins follows:
Rab4
Rab4 is localized to the early endosome along with Rab5 and Rab11 (Sonnichsen, De
Renzis et al. 2000). However, Rab4 only affects trafficking to recycling and autophagy pathways
and facilitates the formation of late endosomes and recycling endosomes (Vandersluijs, Hull et
al. 1991, Vandersluijs, Hull et al. 1992, McCaffrey, Bielli et al. 2001). Rab4 initiates a small
cascade of adaptor proteins that direct trafficking to other organelles and that also triggers the
formation of endosomes (D’Souza, Semus et al. 2014). Rab4 overexpression does not influence
endocytosis but changes the accumulation of recycling markers (TfRs) that could have an effect
on the recycling pathway (Vandersluijs, Hull et al. 1992). Due to its involvement in the
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endocytic and recycling pathways, Rab4 has also been associated with APP processing in
neurons.
Rab4 is upregulated in forebrain neurons from mild cognitive impairment and AD
patients, which suggests a role with AB accumulation (Ginsberg, Mufson et al. 2011, Soejima,
Ohyagi et al. 2013). Indeed, independent studies found accumulation of exogenous Aβ42 in
Rab4 compartments in the early endosome (Arriagada, Astorga et al. 2007, Arriagada,
Bustamante et al. 2010). Enlargement of early endosomes, which is a hallmark of Rab5
overexpression, was also associated with increase of Rab4; suggesting that Rab4 and Rab5 might
have similar functions in early endosomes and endocytosis. Finally, Udayar et al (2013) reports
that silencing of Rab4 decreased production of Aβ42 and sAPP-B (Udayar, Buggia-Prevot et al.
2013). These studies agree that Rab4 and Rab5 are affected in early AD pathology and that Rab4
and Aβ42 accumulation in the early endosome leads to endocytosis and recycling dysfunction.
However, further studies are needed to confirm this association.
Rab8
Rab8 is ubiquitously expressed in most cells and localizes to the TGN, vesicular
structures and basolateral plasma membrane. In trafficking mechanisms, Rab8 regulates
retrograde and anterograde transport between these structures (Huber, Pimplikar et al. 1993).
Interestingly, Rab8 has a key role in regulating cell shape by the interaction of actin and
microtubules with membrane trafficking. Rab8 also plays an important role in other cell
processes such as ciliogenesis, cell migration, exocytosis and receptor exchange in the basal
body (Peranen, Auvinen et al. 1996, Sato, Mushiake et al. 2007, Knodler, Feng et al. 2010,
Peränen 2011).
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In neurons, Rab8 regulates anterograde trafficking to the dendrites but not to the axons
and it is required for neurite outgrowth (Huber, Dupree et al. 1995). This is supported by the
observation that Rab8 depletion inhibits neuritic growth and mediates polarized membrane
transport (Hattula and Peranen 2005). It is possible that Rab8 serves a similar function as Rab6
and Rab3 in anterograde transport of APP to the dendrites. This is supported by the observation
that mutations in PSEN1 disturb APP transport and down regulates Rab8 levels in PC12 cells
(Kametani, Usami et al. 2004). Analysis of small G proteins (Ras, Ral & Rab) from AD brains
identified a significant increase of Rab8 only in the cell membrane whereas other Ras and Rab
GTPases decreased in the cytoplasmic region (Shimohama, Kamiya et al. 1999). A similar
observation showed that a PSEN1 mutation increased Aβ42 levels in vesicles containing Rab8.
These vesicles accumulated in the late stages of the secretory pathway between the TGN and cell
membrane (Petanceska, Seeger et al. 2000). Interestingly, previous studies presented here do not
show the same observation in upregulated Rab GTPases in AD brains (Ginsberg, Alldred et al.
2010, Ginsberg, Mufson et al. 2010). Finally, RNAi screening for GTPases showed that silencing
of Rab8 increased intracellular Aβ42 levels, indicating a possible neuroprotective effect of Rab8
(Udayar, Buggia-Prevot et al. 2013). These reports suggest a likely interaction of Rab8 with
PSEN1 and APP via the secretory pathway as well as a possible protective effect on Alzheimer’s
disease pathogenesis. Further studies need to confirm this association and establish a more
relevant role of Rab8 in neurodegeneration.
Rab10
Rab10 is another dynamic GTPase involved mainly in anterograde transport and in the
recycling pathway. Rab10 belongs to a Rab subfamily that includes Rab8 and Rab13 and shares
about 66% homology with Rab8; however, both localize to different organelles in the cell (Chen,
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Holcomb et al. 1993). Similar to Rab8, Rab10 is involved in numerous cell processes and
functions including endocytosis (Babbey, Ahktar et al. 2006), ciliary transport (Babbey, Bacallao
et al. 2010), phagosome maturation (Cardoso, Jordao et al. 2010), cell polarization (Schuck, Gerl
et al. 2007) and insulin GLUT4 transport (Sano, Eguez et al. 2007, Chen, Wang et al. 2012).
Even though Rab10 shares similar homology and functions to Rab8, most literature suggests a
complimentary role to Rab11 in the recycling pathway. In C elegans, Rab10 is required for
proper recycling function and trafficking from the early endosome to the recycling endosome
and from there to the basolateral membrane (Chen, Schweinsberg et al. 2006, Schuck, Gerl et al.
2007). Finally, Rab10 seems to be a main regulator of organelle shape and morphology by
associating with microtubules. A recent study shows that Rab10 has given a key role in the
regulation of ER dynamic growth and morphology by associating with microtubules (Chang and
Blackstone 2013, English and Voeltz 2013). A separate study shows that Rab10 is necessary for
microtubule network growth in the basolateral recycling pathway in endosomes (Chen, Li et al.
2014).
In neurons, Rab10 is associated with anterograde transport of receptors that promote axon
development and neuronal polarization. Rab10 binds to a specific number of effectors including
Myosyn Vb, Lgl1, JIP1 and MARCKS in post-TGN vesicles that carry axonal receptors
responsive to axonal growth factors (Wang, Liu et al. 2011, Liu, Xu et al. 2013, Deng, Lei et al.
2014, Xu, Deng et al. 2014). Despite its involvement in anterograde and recycling mechanisms,
only one study links Rab10 with APP and amyloid processing. In the previously mentioned
RNAi expression screen, silencing of Rab10 decreased Aβ42 production without affecting sAPPB levels. This study also suggested of an interaction of Rab10, Rab23 & Rab25 in regulating the
same trafficking pathways (Udayar, Buggia-Prevot et al. 2013). In adipocytes, Rab10
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knockdown resulted in an attenuation of Glut4 redistribution to the plasma membrane and a twofold decrease of Glut4 exocytosis rate (Sano, Eguez et al. 2007). Together, these studies
underscore a role of Rab10 in anterograde transport of important cell receptors and exocytosis of
recycled peptides. It is possible that Rab10 regulates transport of APP molecules and Aβ42 to the
cell membrane via the constitutive secretory and recycling pathways. However, further studies
are needed to confirm this association, making Rab10 a promising marker in AD pathogenesis.

Conclusion
Rab GTPases are involved in most intracellular trafficking, endocytosis, recycling and
exocytosis in the cell. They are also involved in numerous processes such as organelle formation,
response to stimuli, cell migration, etc. Due to their important role in these processes, Rab
GTPases provide important insight into mechanisms involved in disease progression and
signaling such as Cancer, diabetes, anemia and neurological diseases. In this review, we focused
on Rab GTPases that have been mainly associated with Alzheimer’s pathogenesis in endocytosis,
recycling and degradation pathways of APP and Aβ42. In addition, we presented Rab proteins
with limited association with neurodegeneration and how these could provide future insights in
this process. Future directions could be finding mechanisms mediated by Rab proteins that offer
protective effects towards neurotoxicity. In addition, therapeutic approaches that could rescue
processes such as endocytosis and recycling pathways in early stages of neurodegeneration could
prove to be effective in controlling cascade of events that lead to AD pathology.
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Figure 1 – Schematic of Rab GTPases involved in APP trafficking in the cell. This figure
represents a likely model for the role of specific Rab proteins in APP and AB transport in the
cell. Retrieved from (Udayar, Buggia-Prevot et al. 2013).
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Chapter 2: Expression Effects of Rab10 and Sar1A GTPases in APP and
Aβ Levels in N2A-695 Cells
Abstract
Rab proteins are members of a large family of monomeric GTP binding proteins that are
key players in numerous steps of cellular transport ranging from intracellular transport to
endocytosis and autophagy. Several studies show increased levels of particular Rab proteins in
Alzheimer’s pathogenesis. Previous experiments indicate an association with Rab10 with
amyloid generation and Alzheimer’s disease risk. Here we show an experimental approach used
to characterize the effects of Rab10 and Sar1A GTPases in APP and amyloid processing. N2A
cells were transient transfected with overexpression and shRNA plasmids and their effects in
APP expression and Aβ40 and Aβ42 were measured using sandwich ELISA. We found that
Rab10 expression does not affect APP production but significantly changes AB generation,
particularly the toxic Aβ42. On the other hand, we found no significant effect of Sar1A
expression on either APP or amyloid beta generation. These findings partially confirm the work
done by Kauwe et al (2015) and provide preliminary evidence for two potential targets for
protective effects in neurodegeneration.
Introduction
Alzheimer’s disease is the 6th most prevalent cause of death in US with an estimated
500,000 fatalities each year due to the disease (Alz.org retrieved 2014). A major neurological
hallmark of the disease is the accumulation of senile plaques composed of amyloid beta
molecules. The most accepted theory behind the pathogenesis of Alzheimer’s is known as the
amyloid cascade hypothesis (Hardy and Higgins 1992, Ridge, Ebbert et al. 2013). Briefly,
amyloid beta molecules are produced by cleavage of APP by beta and gamma secretases
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producing fragments ranging from 39-43 amino acids. Aβ42 is the peptide most susceptible to
aggregation and it is the main component of the senile plaques (Thinakaran and Koo 2008, Tam,
Seah et al. 2014). Accumulation of senile plaques in the brain disrupts neuronal connections and
synapses, causing oxidative stress on neurons that form neurofibrillary tangles and apoptosis that
lead to widespread neurodegeneration (Masters, Multhaup et al. 1985, Hung, Koo et al. 1992,
Selkoe 2001, Ring, Weyer et al. 2007, Oh, Savonenko et al. 2009, Hashimoto and Matsuoka
2014). Interestingly, Aβ40 is by far the most common product from APP cleavage but does not
aggregate into senile plaques. The change in Αβ40:42 ratio is generally considered to contribute
to Aβ42 deposition and neurotoxicity.
Transmembrane APP undergoes the constitutive secretory pathway in the cell where it is
post-translationally modified in the ER and TGN to be transported via anterograde transport to
the cell membrane. APP is then internalized via endocytosis to the cell where it is processed by
the recycling and autophagy machineries (Kins, Lauther et al. 2006, Nixon 2007, Thinakaran and
Koo 2008, Thomas, Lelos et al. 2011, Haass, Kaether et al. 2012). Aβ production occurs mainly
on the endosomal – lysosomal systems and has also been detected in compartments of the TGN
(LeBlanc and Goodyer 1999, Haass, Kaether et al. 2012, Lu and Hong 2014). The majority of
AB fragments are then secreted via exocytosis where Aβ42 aggregates in the extracellular space
(Yu, Cuervo et al. 2005, Nixon 2007). However, small quantities of Aβ42 stay in the cell where
they contribute in disrupting cellular pathways. Polymorphisms in proteins involved in the
transporting and processing of APP have been associated with differential Aβ-42 deposition and
a change in the Αβ40:42 ratio (Citron, Westaway et al. 1997, Cataldo, Peterhoff et al. 2000,
Jankowsky, Fadale et al. 2004, Lee, Yu et al. 2010, Ridge, Ebbert et al. 2013). In this context,
GTPases are small proteins involved in processes such as vesicle formation, transport, signal
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transduction, translocation and processing of membrane proteins (Zerial and McBride 2001,
Seabra, Mules et al. 2002, Grosshans, Ortiz et al. 2006). Expectedly, various studies show that
APP and Aβ production is influenced by specific GTPases (Cataldo, Peterhoff et al. 2000,
Reddy, Mani et al. 2005, Baskys, Bayazitov et al. 2007, Udayar, Buggia-Prevot et al. 2013,
Armstrong, Mattsson et al. 2014, Buggia-Prevot, Fernandez et al. 2014, Tan, Lee et al. 2014).
This study focused on two small GTPases not previously associated with AB generation: Rab10
and Sar1A.
Rab10
Rab10 is a member of the Ras superfamily of small GTPases. In general, Rab GTPases
are involved in every step of the intracellular vesicle transport in the cell (Stenmark and
Olkkonen 2001, Seabra, Mules et al. 2002). In addition to trafficking, some Rab proteins seem to
play an important role in organelle shape and growth by associating with microtubules (Zerial
and McBride 2001, Seabra, Mules et al. 2002, Grosshans, Ortiz et al. 2006). Rab proteins switch
between an inactive (GDP-bound) cytosolic state and active (GTP-bound) membrane bound
state. Among other cellular processes, Rab10 has two main roles: regulating ER dynamics and
anterograde transport to the plasma membrane (Schuck, Gerl et al. 2007, English and Voeltz
2013, Liu, Xu et al. 2013, Deng, Lei et al. 2014). English et al (2013) showed that Rab10
localizes in the ER and associates with microtubules to direct ER growth. Mutant Rab10 show an
altered ER morphology and reduced ability to fuse with adjacent ER tubules (English and Voeltz
2013). Independent studies show that Rab10 has an active role in transporting cell receptors to
and from the TGN to the plasma membrane (Sano, Eguez et al. 2007, Schuck, Gerl et al. 2007,
Lerner, McCoy et al. 2013, Deng, Lei et al. 2014). In neurons, Rab10 promotes axon
development and neuronal polarization by transporting axonal receptors that interact with
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extracellular growth factors (Wang, Liu et al. 2011, Liu, Xu et al. 2013, Xu, Deng et al. 2014).
Additional evidence suggests a particular role of Rab10 in the endosome – recycling pathways
(Babbey, Ahktar et al. 2006, Chen, Schweinsberg et al. 2006, Chen, Li et al. 2014). In a recent
RNAi screen of all human Rab GTPases, Rab10 was found to decrease Aβ42 production and to
affect sAPP-B levels in neural cells (Udayar, Buggia-Prevot et al. 2013).
Sar1A
Sar1A is another member of the Ras supefamily of small GTPases, involved in vesicle
transport and membrane rigidity. In mammals, the two Sar1 isoforms (Sar1A and Sar1B) contain
89% homology. However, Sar1A is commonly referenced as Sar1 (Bi, Corpina et al. 2002,
Loftus, Hsieh et al. 2012). Unlike Rab10, which localizes to vesicles throughout the secretory
and recycling pathways, Sar1A is only localized to the ER, particularly in COPII vesicles. COPII
transport is the first step of the secretory pathway for most secreted proteins starting with the ER
(Wang and Wu 2012, Zanetti, Pahuja et al. 2012, Cutrona, Beznoussenko et al. 2013). Sar1A is a
principal component of COPII vesicle formation and transport from the ER to the Golgi
(Barlowe, d'Enfert et al. 1993, Kuge, Dascher et al. 1994, Long, Yamamoto et al. 2010). In its
active GTP form, Sar1A triggers vesicle formation by binding with the ER membrane to recruit
other COPII components. Depletion of Sar1A severely disrupts COPII assembly and transport
from the ER to Golgi (Cutrona, Beznoussenko et al. 2013). Sar1A also decreases rigidity of the
membrane that is bound, either by associating with lipid bilayers or with microtubules (Long,
Yamamoto et al. 2010, Loftus, Hsieh et al. 2012, Riggs, Bergman et al. 2012, Fokin, Brodsky et
al. 2014). This observation is supported by recent studies that link polymorphisms along Sar1A
with the development of membrane structure deficiencies such as sickle cell and Anderson
disease (Pepperkok, Lowe et al. 1998, Kumkhaek, Zhu et al. 2007, Kumkhaek, Taylor et al.
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2008, Georges, Bonneau et al. 2011). Interestingly, both Rab10 and Sar1A have an important
role in regulating anterograde transport and ER structure by interacting with microtubules.
However, a specific link with neurodegenerative diseases has not been previously established.
Recent unpublished work by Kauwe (2015) and collaborators discovered two rare
variants in Rab10 (rs1427874) and Sar1A (rs7653) that influence Alzheimer’s disease risk.
Rab10 and Sar1A have not previously been associated with APP transport or amyloid
production. We sought to characterize the effects of differential expression of Rab10 and Sar1A
on APP and Aβ production in murine N2A/APP695 cells. We found that differential expression
of Rab10 change Αβ42/Αβ40 ratio and influences Aβ42 production.
Results
Rab10 & Sar1A expression does not affect full-length APP
We sought to first test the effects of cellular Rab10 and Sar1A overexpression on full
length APP. We transfected pCMV6-Rab10 and pCMV6-Sar1A overexpression plasmids in
N2A/APP695 mouse cells. At 48 h after transfection, cells were harvested and protein expression
was measured using 6E10 and 9E10 antibodies as described in methods section. Fig 1 shows that
full-length APP expression is the same in GFP control lanes with Rab10 and Sar1A transfected
cells. We further tested whether this observation by immunoblotting with three different
gradients of protein aliquots (25 ug/uL, 37.5 ug/uL and 50 ug/uL). The results were the same as
before, indicating that APP, Rab10 and Sar1A exposure increase proportionally to the total
protein immunoblotted (not shown). Similarly, we measured APP expression of transfected
N2A/APP695 cells with shRNA plasmids that produced a 62% knockdown of Rab10 and a 26%
knockdown of Sar1A. Fig 1 also shows no visible change in full length APP between the
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scrambled plasmid and the knockdown plasmids. Together, these results show that full length
APP is not affected by overexpression of Rab10 and Sar1A.
Rab10 expression alters Aβ whereas Sar1A does not change Aβ levels.
Next, we sought to quantify the effect of varying expression of Rab10 and Sar1A on Aβ
levels. A sandwich ELISA measuring Aβ40 and Aβ42 levels was performed from cell media
obtained from transient transfected cells with overexpression and shRNA plasmids for Rab10
and Sar1A. We observed increased levels of Aβ42 levels and an increased Aβ40:42 ratio (Fig
2A, p = 0.0017) in cells overexpressing Rab10. Conversely, we observed the opposite effect in
knockdown Rab10 cells, resulting in decreased Αβ42 levels and a decreased Aβ40:42 ratio (Fig
2B), however, the p-value was verily significant p = 0.048. On the other hand, no change in
AB42 levels and AB40:42 ratios were observed in both overexpressed and knockdown Sar1A
cells (Fig 3, p-value not shown). Together, these results show that Rab10 plays a role in APP
processing but not on full-length expression whereas the expression effects of Sar1A were did
not significantly influence APP expression and processing.
Discussion
Here we show that Rab10 expression significantly affects amyloid generation while
maintaining stable levels of APP in N2A-695 cells. This is the first study that presents primary
evidence linking Rab10 with APP and Aβ production following preliminary results from Udayar
suggesting this effect on Rab10 knockdown (Udayar, Buggia-Prevot et al. 2013). A possible
hypothesis surrounding these observations might be that Rab10 does not directly interact in the
secretory pathway of APP. Even though Rab10 heavily regulates ER dynamics and morphology
(English and Voeltz 2013), it could be possible that Rab10 does not directly transport APP in
anterograde fashion to the axons and synapses. APP is prevalent in axonal cones and evidence
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shows that one of the trophic functions of APP is to promote axon development (Kins, Lauther et
al. 2006, Sosa, Bergman et al. 2013). Interestingly, Rab10 also promotes axon development and
elongation by facilitating the transport of membrane receptors such as GLUT4 (Liu, Xu et al.
2013, Sano and Eguez 2007). Nascent APP molecules could be a specific cargo to another Rab
GTPases such as Rab3 and Rab6, which have been shown to transport APP to axons and neurites
(McConlogue, Castellano et al. 1996, Szodorai, Kuan et al. 2009).
The significant observation of Rab10 in amyloid beta generation suggests a downstream
effect in the APP processing pathway. A second hypothesis explaining the results of this study is
that Rab10 participates in AB processing following APP endocytosis. Rab10 also localizes to the
recycling and sorting endosomes and mediates vesicle transport from basolateral endosomes to
early and late endosomes (Babbey, Ahktar et al. 2006, Chen, Schweinsberg et al. 2006). This
transport is part of endosomal pathways where proteins are taken to and from the plasma
membrane to be degraded by authophagy or recycled back to the plasma membrane. Expression
changes of Rab10 might accelerate or suppress transport between endosomes as part of recycling
and autopaghy processes of APP. Future experiments specifically tracking endosomal transport
will prove useful to determine the precise role of Rab10 in amyloid beta transport.
Conversely, we did not see a significant effect of Sar1A expression in both APP
expression and amyloid processing. Since Sar1A only localizes to ER compartments and vesicles
leading to the Golgi, it is possible that similar to Rab10, Sar1A is not directly involved in APP
anterograde transport (Kuge, Dascher et al. 1994, Cutrona, Beznoussenko et al. 2013). Even
though a direct role of Sar1A in amyloid beta production seems unlikely due to its localization in
the cell, it should not be completely discarded. Our preliminary results support the former by not
showing any interesting effects on Aβ. However, in N2A cells transfected with shRNA plasmids,
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we only obtained a 26% total knockdown of Sar1A. We considered this knockdown percentage
to be enough to obtain observable conclusions regarding Sar1A role in amyloid beta generation.
Another factor that might influence in our results was the number of replicated used. We only
used three replicates in our sandwich ELISA to evaluate total Aβ42 and Aβ40 production. It is
possible that by increasing the number of replicates would and knockdown conditions by the use
of other RNAi methods could influence these results. Further experiments including these
recommendations and other cell imaging methods could be used to confirm these results.
In closing, these results support previous observations where silencing of Rab10
decreases only Αβ (Udayar, Buggia-Prevot et al. 2013) and show that the opposite also applies in
higher Aβ generation. In addition, these results offer preliminary evidence supporting results by
Kauwe et al (2015) where polymorphisms on the 3’UTR of Rab10 affect Alzheimer’s disease
risk. The next step will be to repeat the methods used in this study in N2A-695 cells expressing
rs14278789 (Rab10) to further confirm the functional effect of this genetic variation in
Alzheimer’s.
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Methods
Plasmids
The plasmids used for this study were the following: pCMV6-Rab10 (Origene #
RC201464), pCMV6-Sar1A (Origene # RC201450) for the overexpression experiments. pGFPV-RS-Rab10 shRNA (Origene #TG501823) and pGFP-V-RS-Sar1A shRNA (Origene
#TG501970). Four shRNA versions per gene were tested to obtain greater knockdown levels.
Cell culture
Mouse neuroblastoma cells (N2A/APP695) expressing human APP-695 isoform were
kindly given by Celeste Karch, Ph.D. N2A/APP695 are a mouse neuroblastoma line that express
human APP695 isoform and is commonly used in functional APP studies (Thinakaran, Teplow et
al. 1996, Rajendran, Honsho et al. 2006, Wang, Wang et al. 2006). N2A/APP695 cells were
plated and grown in Dulbecco’s modified eagle medium (DMEM) and Opti-MEM (1:1)
supplemented with 1% L-glutamine, 5% FBS and 1% anti-mycotic solution. Cells were grown
between 80% to 90% confluence for posterior analyses. Upon confluency, cells were transiently
transfected using Lipofectamine 2000 (Invitrogen). Culture media was changed 24 h after
transfection. Following 48 h after transfection, cell media was collected and centrifuged for 10
minutes at 4°C and protease inhibitor was added for peptide preservation. Cell pellets were
collected, lysed and centrifuged with protease inhibitor to collect total protein. Protein
concentration was measured using a BCA method in preparation for immunoblotting.
Transfection and reporter gene assays
Functional assays of reporter gene constructs were performed by transient transfection of
N2A/APP695 cells using Lipofectamine 2000 reagent (Life Technologies). Cells were allow to
confluence between 85 to 90% and transfected with and pCDNA control vector to bring total
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DNA concentration 1.0 μg. Cells were growth for 48 h; following this time, media was collected
for ELISA assays. Cells were washed and RNA was isolated from cells for RT-qPCR or lysed to
assess protein concentration by Western blot analysis.
RNA isolation and RT-PCR analysis
In order to assess greatest knockdown, total RNA was isolated from N2A/APP695 cells
after transfection with four plasmids containing specific shRNA for knockdown of either Rab10
or Sar1A genes. RNA was extracted from cells 48 h following transfection using RNeasy
(Qiagen) following manufacturer protocol. RNA was converted to cDA using High-capacity
cDNA reverse transcription (ABI). Following RT-PCR, Taqman real time PCR assays were used
to observe the expression of Rab10 (Mm00489481_m1) and Sar1A (Mm01150424_m1) from
ABI technologies. Total gene expression was quantified in triplicates using an ABI-7900 RealTime PCR system. A housekeeping gene GAPDH was used for normalizing expression values
using the CT method.
Protein analysis
N2A/APP695 cell lysates were used to assess Rab10, Sar1A and APP695 protein
expression by SDS-PAGE and Western blot analysis with primary mouse 9E10 or 6E10
polyclonal antibody and goat-anti mouse polyclonal as secondary antibody. Briefly, equivalent
amounts of total protein were evaluated by SDS-PAGE, blocked with 5% nonfat milk, and
exposed to the primary antibody diluted at 1:5000 at 4°C overnight. Exposure to the secondary
antibody was carried at 1:2000 for 2 h. Blots were exposed with enhanced chemiluminescence
(Lumigen TMA-6).
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Enzyme-linked immunosorbent assay
The levels of Aβ40 and Aβ42 were measured from collected cell culture media by
sandwich ELISA as described by the manufacturer (Invitrogen). ELISA values were obtained
(pg/mL) and corrected for total intracellular protein (ug/mL) based on BCA measurements.
Statistical analysis
Values are expressed as mean ± SD obtained from at least three separate experiments in
each group. Data were assessed by one-way analysis of variance (ANOVA). When ANOVA
indicated significant differences, the Student's t-test was used with Bonferroni correction for
multiple comparisons. Results presented are representative and those with P values <0.05 were
considered significant.
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Figure 2: Expression of Rab10 and Sar1A does not affect full length APP. This figure shows an
immunoblot using the following legends: lanes 1- GFP, lane 2 – GFP + Rab10, lane 3GFP+Sar1A, lane 4 – Scrambled shRNA, lane 5 – scrambled + Rab10 shRNA, lane 6 –
scrambled + Sar1A.
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Figure 3: Rab10 expression influences Aβ42 and Aβ42/aβ40 ratio. Figure 3A shows the results
from a sandwich ELISA in N2A-695 cells transfected with overexpression and shRNA plasmids.
Experiments and their respective controls (GFP for overexpression and Scrambled for shRNA)
are depicted on Aβ42 (left), Aβ40 (middle) and Aβ42/Aβ40 ratio (right) panels. Each bar
represents the results from six replicates. Figure 2B shows the effects of Rab10 for Aβ42/Aβ40
ratio only. Each bar represents the results from 10 replicates.
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Figure 4: Sar1A expression does not influence Aβ42 and Aβ42/Aβ40 ratio. This figure
shows the results from the sandwich ELISA in N2A-695 cells transfected with overexpression
and shRNA plasmids. Experiments and their respective controls (GFP for overexpression and
Scrambled for shRNA) are depicted on Aβ42 (left), Aβ40 (middle) and Aβ42/Aβ40 ratio (right)
panels. Each bar represents the results from three replicates.
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